| ²é¿´: 1814 | »Ø¸´: 5 | |||
xf023ľ³æ (СÓÐÃûÆø)
|
[ÇóÖú]
ÇóÖú°ÂÀÎ÷̹¹úÍâÉÏÊÐÐÅÏ¢
|
|
Çë¸ßÊÖ°ïæ²éÒ»ÏÂPharmaProjectsÖ®ÀàµÄÊý¾Ý¿â£¬Ð¡µÜÔÚÕâлÁË¡£ Ò©Æ·Ãû³Æ£º°ÂÀÎ÷̹ Ó¢ÎÄÃû£ºOxiracetam ÉÌÆ·Ãû£ºneuromet¡¢neupan Ïë²éÒ»ÏÂÃÀ¹ú£¬Å·ÖÞ£¬ÑÇÖÞÖ÷Òª¹ú¼ÒµÄ¾ßÌåÉÏÊÐʱ¼ä¡£ |
» ²ÂÄãϲ»¶
ÄÄÀï×ö¸Ê°±ËáÊÜÌåÓëÅäÌå½áºÏÂʵÄÊÔÑé
ÒѾÓÐ0È˻ظ´
͸Ã÷ÖÊËá ¼×»ù±ûÏ©Ëáôû
ÒѾÓÐ0È˻ظ´
Ò©ÀíѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ77È˻ظ´
305²ÄÁÏר˶µ÷¼Á
ÒѾÓÐ12È˻ظ´
¹ØÓÚSCIÔÓÖ¾·¢±í¹ÒÃû
ÒѾÓÐ32È˻ظ´
CSC¸ÄÅÉ-²©Ê¿Éú½»Á÷·Ãѧ
ÒѾÓÐ19È˻ظ´
ÖÐɽ´óѧ-µÚÆßÒ½Ôº-ÕпÆÑÐÖúÀí1Ãû£¨»ùÒòÉè¼ÆºÍ¿Ë¡¡¢RNAºÏ³É£©
ÒѾÓÐ0È˻ظ´
ÖÐɽ´óѧ-µÚÆßÒ½Ôº-ÕпÆÑÐÖúÀí1Ãû£¨»ùÒòÉè¼ÆºÍ¿Ë¡¡¢RNAºÏ³É£©
ÒѾÓÐ1È˻ظ´
°ÍÀèÈø¿ËÀ×´óѧÓë¹ú¼ÒÁôѧ»ù½ðίºÏ×÷²©Ê¿Ñо¿ÉúÏîÄ¿-Ö¬ÖÊÄÉÃ×Ò©Îï/ÉúÎï²ÄÁÏ/¶à·ÓµÝËÍ
ÒѾÓÐ10È˻ظ´
½õÖÝÒ½¿Æ´óѧҩÓÃÉúÎï²ÄÁÏ£¨×¨Òµ´úÂë1007Z1£©ÕÐÊÕµ÷¼Á¿¼Éú
ÒѾÓÐ0È˻ظ´
½õÖÝÒ½¿Æ´óѧҩÓÃÉúÎï²ÄÁÏ£¨×¨Òµ´úÂë1007Z1£©ÕÐÊÕµ÷¼Á¿¼Éú
ÒѾÓÐ1È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
ÔÚ¹úÍâÌîд¹ú»ù½ðÓöµ½ºêÏÔʾºÍÊäÈëÖÐÎÄÂÒÂë½ô¼±ÇóÖú£¡
ÒѾÓÐ4È˻ظ´
ÇóÖú£ºÄÄλ¸ßÈËÄÜÌṩһϹúÍâ×öº£Ë®/Ñκþ/±ˮµÈÌáȡﮱȽϺõĽÌÊÚÐÅÏ¢
ÒѾÓÐ5È˻ظ´
ÇóÖú¹úÍâÄÄЩ´óѧÕÐÆ¸²©Ê¿
ÒѾÓÐ12È˻ظ´
¡¾ÇóÖú¡¿ÒÑÔÚ¹úÍâ¹úÄÚ¾ùÉÏÊеÄϸ°û·¢½ÍÉúÎïÖÆÆ·ÊôÓÚÄÄÒ»Àࣿ
ÒѾÓÐ6È˻ظ´
¡¾ÇóÖú¡¿Çë½Ì¸÷λ¶Ô°ÂÀÎ÷̹ÔÚ¹úÍâµÄÉÏÊÐÇé¿ö
ÒѾÓÐ7È˻ظ´
¡¾ÇóÖú¡¿Ç󣺰ÂÀÎ÷̹ºÏ³É¹¤ÒÕ£¬¿ØÖƳɱ¾600ÒÔÏÂ
ÒѾÓÐ11È˻ظ´
¡¾ÇóÖú¡¿¹úÍâÉÏÊÐÒ©Æ·µÄÐÅÏ¢
ÒѾÓÐ14È˻ظ´
¡¾ÇóÖú¡¿ÇëÎÊÔÚ¹úÍâÉÏÊУ¬Î´ÔÚÖйúÉÏÊеÄÒ©ÎïÊǼ¸ÀàÐÂÒ©
ÒѾÓÐ33È˻ظ´
alpha
гæ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 767.6
- Ìû×Ó: 116
- ÔÚÏß: 46.5Сʱ
- ³æºÅ: 143347
- ×¢²á: 2005-12-22
- ÐÔ±ð: GG
- רҵ: Ò©ÎïÉè¼ÆÓëÒ©ÎïÐÅÏ¢
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
xf023(½ð±Ò+5): 2011-08-03 15:46:48
|
Country Name Status Year Launched Licensing Op. Argentina Preclinical No Australia - No Austria - No Belgium - No Brazil Pre-registration No Canada - No Chile - No China - No Colombia - No Denmark - No Finland - No France - No Germany - No Greece Pre-registration No Hong Kong - No India - No Ireland - No Israel - No Italy Launched 1987 No Japan Pre-registration No Luxembourg - No Malaysia - No Mexico Preclinical No Netherlands - No New Zealand - No Norway - No Peru - No Philippines - No Portugal Launched 1991 No Russian Federation - No South Africa - No South Korea Registered No Spain - No Sweden - No Switzerland Preclinical No Thailand - No Turkey - No UK - No USA Phase III Clinical Trial No Venezuela - No |
2Â¥2011-08-03 14:34:05
xf023
ľ³æ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 2565
- Ìû×Ó: 282
- ÔÚÏß: 52.4Сʱ
- ³æºÅ: 100686
- ×¢²á: 2005-11-12
- ÐÔ±ð: GG
- רҵ: Ò©Îﻯѧ
3Â¥2011-08-03 15:40:43
spring_sunny
гæ (³õÈëÎÄ̳)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 14.3
- Ìû×Ó: 20
- ÔÚÏß: 17.4Сʱ
- ³æºÅ: 913521
- ×¢²á: 2009-11-26
- ÐÔ±ð: GG
- רҵ: ÖÐҩѧ
4Â¥2011-11-15 10:34:21
alpha
гæ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 767.6
- Ìû×Ó: 116
- ÔÚÏß: 46.5Сʱ
- ³æºÅ: 143347
- ×¢²á: 2005-12-22
- ÐÔ±ð: GG
- רҵ: Ò©ÎïÉè¼ÆÓëÒ©ÎïÐÅÏ¢
|
USA Phase III Clinical Trial No Italy Launched 1987 No ²ÎÕÕÕ⼸¸ö¾ÍÖªµÀÁË£¬NOÖ¸µÄÊÇLicensing Opp |
5Â¥2011-11-15 20:30:13
tango_lizy
½ð³æ (ÕýʽдÊÖ)
Ò©½³Ñ§Í½
- Ó¦Öú: 11 (СѧÉú)
- ½ð±Ò: 800.2
- É¢½ð: 200
- ºì»¨: 50
- Ìû×Ó: 405
- ÔÚÏß: 93.9Сʱ
- ³æºÅ: 1107041
- ×¢²á: 2010-09-25
- ÐÔ±ð: GG
- רҵ: ºÏ³ÉÒ©Îﻯѧ

6Â¥2011-11-15 22:17:40













»Ø¸´´ËÂ¥